Thromboxane A2 (TP) receptor in the non-pregnant porcine myometrium and its role in regulation of spontaneous contractile activity

European Journal of Pharmacology

Volumn 485, Issue 1-3, 2004, Pages 317-327

  Cao, Jinshan ^a   Wakatsuki, Akira ^a   Yoshida, Munenori ^a   Kitazawa, Takio ^a   Taneike, Tetsuro ^a  

^a RAKUNO GAKUEN UNIVERSITY   (Japan)

Author keywords

Contractility, spontaneous; Pig; Prostanoid TP receptor; Thromboxane A2; U46619; Uterus

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 15 HYDROXY 9ALPHA,11ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; 6 [2 (2 CHLOROPHENYL) 4 (2 HYDROXYPHENYL) 1,3 DIOXAN 5 YL] 4 HEXENOIC ACID; 7 [3 [(4 PHENYLSEMICARBAZIDO)METHYL] 7 OXABICYCLO[2.2.1]HEPT 2 YL] 5 HEPTENOIC ACID; BM 531; INDOMETACIN; PROSTANOID RECEPTOR; RECEPTOR SUBTYPE; SULFONYLUREA DERIVATIVE; THROMBOXANE A2 RECEPTOR; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG BINDING SITE; DRUG EFFECT; INTERMETHOD COMPARISON; NONHUMAN; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; RECEPTOR OCCUPANCY; SMOOTH MUSCLE CONTRACTILITY; UTERUS CONTRACTILITY; ANIMAL; COMPARATIVE STUDY; DOSE RESPONSE; FEMALE; IN VITRO STUDY; METABOLISM; MUSCLE CONTRACTION; MYOMETRIUM; PHYSIOLOGY; PROTEIN BINDING; SWINE;

15-HYDROXY-11 ALPHA,9 ALPHA-(EPOXYMETHANO)PROSTA-5,13-DIENOIC ACID; ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MUSCLE CONTRACTION; MYOMETRIUM; PROTEIN BINDING; RECEPTORS, THROMBOXANE A2, PROSTAGLANDIN H2; SWINE;

EID: 1642538360     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2003.11.073     Document Type: Article

References (46)

1. Boersma J.I., Janzen K.M., Oliveira L., Crankshaw D.J. Characterization of excitatory prostanoid receptors in the human umbilical artery in vitro. Br. J. Pharmacol. 128:1999;1505-1512.
2. Cao J., Shayibuzhati M., Tajima T., Kitazawa T., Taneike T. In vitro pharmacological characterization of the prostanoid receptor population in the non-pregnant porcine myometrium. Eur. J. Pharmacol. 442:2002;115-123.
3. 50) of an enzyme reaction. Biochem. Pharmacol. 22:1973;3099-3108.
4. 2 receptor in ligand binding. Arch. Biochem. Biophys. 352:1998;207-213.
5. Coleman R.A., Kennedy I., Humphrey P.P.A., Bunce K., Lumley P. Prostanoids and their receptors. Hansch C., Lammes P.G., Taylor J.B. Membranes and Receptors. 1990;643-714 Pergammon, Oxford.
6. Crankshaw D.J. Pharmacological techniques for the in vitro study of the uterus. J. Pharmacol. Toxicol. Methods. 45:2001;123-140.
7. Crankshaw D.J., Gaspar V. Effects of prostanoids on the rat's myometrium in vitro during pregnancy. Biol. Reprod. 46:1992;392-400.
8. Crankshaw D.J., Gaspar V. Pharmacological characterization in vitro of prostanoid receptors in the myometrium of nonpregnant ewes. J. Reprod. Fertil. 103:1995;55-61.
9. Dogne J.M., Rolin S., de Leval X., Benoit P., Neven P., Delarge J., Kolh P., Damas J., David J.L., Maserel B. Pharmacology of the thromboxane receptor antagonist and thromboxane synthase inhibitor BM-531. Cardiovasc. Drug Rev. 19:2001;87-96.
10. Gao Y., Yokota R., Tang S., Ashton A.W., Ware J.A. Reversal of angiogenesis in vitro, induction of apoptosis, and inhibition of AKT phosphorylation in endothelial cells by thromboxane A(2). Circ. Res. 87:2000;739-745.
11. Goureau O., Tanfin Z., Marc S., Harbon S. Diverse prostaglandin receptors activate distinct signal transduction pathways in rat myometrium. Am. J. Physiol. 263:1992;C257-C265.
12. Isaka M., Takaoka K., Yamada Y., Abe Y., Kitazawa T., Taneike T. Characterization of functional endothelin receptors in the porcine myometrium. Peptides. 21:2000;543-551.
13. 2 alpha, a novel noncyclooxygenase-derived prostaglandin, constricts airways in vitro. Am. J. Respir. Crit. Care Med. 153:1996;590-596.
14. 2 alpha. J. Pharmacol. Exp. Ther. 281:1997;957-964.
15. Kitazawa T., Shishido H., Sato T., Taneike T. Histamine mediates the muscle layer-specific responses in the isolated swine myometrium. J. Vet. Pharmacol. Ther. 20:1997;187-197.
16. 7 receptors in inhibition of the porcine myometrial contractility by 5-hydroxytryptamine. Br. J. Pharmacol. 123:1998;173-182.
17. Kitazawa T., Maezono Y., Taneike T. The mechanisms of alpha2-adrenoceptor agonist-induced contraction in longitudinal muscle of the porcine uterus. Eur. J. Pharmacol. 390:2000;185-195.
18. Kitazawa T., Kajiwara T., Kiuchi A., Hatakeyama H., Taneike T. Muscle layer- and region-dependent distributions of oxytocin receptors in the porcine myometrium. Peptides. 22:2001;963-974.
19. Ko F.N., Yu S.M., Kang Y.F., Teng C.M. Characterization of the thromboxane (TP-) receptor subtype involved in proliferation in cultured vascular smooth muscle cells of rat. Br. J. Pharmacol. 116:1995;1801-1808.
20. Kumagai H., Ebashi S., Takeda F. A newer method of biological standardization of the oxytocic principle of the posterior pituitary. Jpn. J. Pharmacol. 2:1952;65-81.
21. Lowry O.H., Rosebrough N.J., Farr A., Randall R.J. Protein measurement with the folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
22. McDonald L.E. Female reproductive system. Veterinary Endocrinology and Reproduction. 2nd Ed. 1975;247-303 Lea & Febiger, Philadelphia.
23. Miggin S.M., Kinsella B.T. Regulation of extracellular signal-regulated kinase cascades by alpha- and beta-isoforms of the human thromboxane A(2) receptor. Mol. Pharmacol. 61:2002;817-831.
24. 2 receptors in the pig. Eur. J. Pharmacol. 160:1989;313-321.
25. Mitchell M.D., Hicks B.R., Thorburn G.D., Robinson J.S. Production of thromboxane B2 by the intra-uterine tissues from late pregnant Rhesus monkeys (Macaca mulatta) in vitro. J. Endocrinol. 79:1978;103-106.
26. Moore F., Asboth G., Lopez B.A. Thromboxane receptor signalling in human myometrial cells. Prostaglandins Other Lipid Mediat. 67:2002;31-47.
27. Narumiya S., Sugimoto Y., Fumitaka U. Prostanoid receptor: structures, properties, and functions. Physiol. Rev. 79:1999;1193-1226.
28. Rolin S., Dogne J.M., Michaux C., Delarge J., Masereel B. Activity of a novel dual thromboxane A(2) receptor antagonist and thromboxane synthase inhibitor (BM-573) on platelet function and isolated smooth muscles. Prostaglandins, Leukot. Essent. Fat. Acids. 65:2001;67-72.
29. Senchyna M., Crankshaw D.J. Characterization of the prostanoid TP receptor population in human nonpregnant myometrium. J. Pharmacol. Exp. Ther. 279:1996;262-270.
30. Senchyna M., Crankshaw D.J. Operational correlates of prostanoid TP receptor expression in human non-pregnant myometrium are unaffected by excision site or menstrual cycle status of the donor. Br. J. Pharmacol. 128:1999;1524-1528.
31. Senior J., Marshall K., Sangha R., Baxter G.S., Clayton J.K. In vitro characterization of prostanoid EP-receptors in the non-pregnant human myometrium. Br. J. Pharmacol. 102:1991;747-753.
32. Senior J., Sangha R., Baxter G.S., Marshall K., Clayton J.K. In vitro characterization of prostanoid FP-, DP-, IP- and TP-receptors on the non-pregnant human myometrium. Br. J. Pharmacol. 107:1992;215-221.
33. Sjoberg T., Steen S. The strong contractile effect of the thromboxane receptor agonist U-46619 in isolated human pulmonary arteries and its competitive antagonism by BM-13.505. Acta Physiol. Scand. 136:1989;161-165.
34. 2 receptor gene in human uterus. Biol. Reprod. 47:1992;105-117.
35. Taneike T., Miyazaki H., Nakamura H., Ohga A. Autonomic innervation of the circular and longitudinal layers in swine myometrium. Biol. Reprod. 45:1991;831-840.
36. Taneike T., Bando S., Takasaki K., Okumura M., Sato H., Teraoka H., Kitazawa T., Ohga A. Muscle layer and regional differences in autonomic innervation and responsiveness to transmitter agents in swine myometrium. J. Auton. Pharmacol. 14:1994;213-227.
37. Taneike T., Narita T., Kitazawa T., Bando S., Teraoka H. Binding and functional characterization of alpha-2 adrenoceptors in isolated swine myometrium. J. Auton. Pharmacol. 15:1995;93-105.
38. 2 receptor antagonist [3H]BAY U 3405 to washed human platelets and platelet membranes. Biochem. Pharmacol. 44:1992;495-503.
39. Van Rossum J.M. Cumulative dose-response curve: II. Techniques for the making of dose response curve in isolated organ and evaluation of drug parameters. Arch. Int. Pharmacodyn. Ther. 143:1963;299-330.
40. Webb M.L., Liu E.C., Monshizadegan H., Hedberg A., Misra R.N., Goldenberg H., Harris D.N. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets. J. Pharmacol. Exp. Ther. 264:1993;1387-1394.
41. Wetzka B., Schafer W., Scheibel M., Nusing R., Zahradnik H.P. Eicosanoid production by intrauterine tissues before and after labor in short-term tissue culture. Prostaglandins. 45:1993;571-581.
42. Wetzka B., Schafer W., Kommoss F., Bettendorf H., Nusing R., Breckwoldt M., Zahradnik H.P. Immunohistochemical localization of thromboxane synthase in human intrauterine tissues. Placenta. 15:1994;389-398.
43. Wilkes B.M., Kaplan R., Mento P.F., Aynedjian H.S., Macica C.M., Schlondorff D., Bank N. Reduced glomerular thromboxane receptor sites and vasoconstrictor responses in diabetic rats. Kidney Int. 41:1992;992-999.
44. Wilkes B.M., Mento P.F., Hollander A.M. Reduced thromboxane receptor affinity and vasoconstrictor responses in placenta from diabetic pregnancies. Placenta. 15:1994;845-855.
45. Wise H., Wong Y.H., Jones R.L. Prostanoid signal integration and cross talk. NeuroSignals. 11:2002;20-28.
46. Zamecnik J., Kennedy T.G., Armstrong D.T. Concentrations of thromboxane B2 and 6-oxo-prostaglandin F1alpha in amniotic fluid, decidual tissue, and placenta in the later stages of pregnancy in the rat. Adv. Prostaglandin Thromboxane Res. 8:1980;1423-1429.